Oslo study: treatment of mild hypertension. A five-year controlled drug study - PubMed (original) (raw)
Clinical Trial
. 1987:47 Suppl 1:108-10.
doi: 10.1159/000184565.
Affiliations
- PMID: 3320783
- DOI: 10.1159/000184565
Clinical Trial
Oslo study: treatment of mild hypertension. A five-year controlled drug study
A Helgeland et al. Nephron. 1987.
Abstract
During 1972-1973, 785 symptom-free men, aged 40-49, with mild hypertension, were randomly assigned to a 5-year controlled drug treatment study, 406 in the treatment group and 379 in the control group. The basic drug was hydrochlorothiazide, in addition methyldopa or propranolol if necessary. The mean observation time was 66 months (range 60-78). At 5 years' follow-up there was no difference in total mortality between treated and controls, nor in cardiovascular mortality. There was a good prevention of cerebrovascular disease (0 vs. 7). Regarding coronary heart disease, however, there was an opposite trend (20 vs. 13, p greater than 0.10). During the trial, different drug-induced changes were observed in serum lipids, glucose and uric acid. The importance of these changes are still uncertain.
Similar articles
- Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3.
Holme I, Kjeldsen SE. Holme I, et al. Eur J Intern Med. 2015 Mar;26(2):123-6. doi: 10.1016/j.ejim.2015.01.013. Epub 2015 Feb 11. Eur J Intern Med. 2015. PMID: 25681139 - Coronary heart disease and treatment of hypertension. Some Oslo Study data.
Leren P, Helgeland A. Leren P, et al. Am J Med. 1986 Feb 14;80(2A):3-6. doi: 10.1016/0002-9343(86)90153-1. Am J Med. 1986. PMID: 2868657 Clinical Trial. - Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.
Helgeland A. Helgeland A. Am J Med. 1980 Nov;69(5):725-32. doi: 10.1016/0002-9343(80)90438-6. Am J Med. 1980. PMID: 7001898 Clinical Trial. - Oslo Hypertension Study.
Leren P, Helgeland A. Leren P, et al. Drugs. 1986;31 Suppl 1:41-5. doi: 10.2165/00003495-198600311-00008. Drugs. 1986. PMID: 2873015 Clinical Trial. - Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS, Farsky K, Bouchard S, Lalonde Y, Brookman S. Farooki MS, et al. Clin Ther. 1985;7(2):199-204. Clin Ther. 1985. PMID: 3886142 Clinical Trial.
Cited by
- Pharmacotherapy for mild hypertension.
Diao D, Wright JM, Cundiff DK, Gueyffier F. Diao D, et al. Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD006742. doi: 10.1002/14651858.CD006742.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895954 Free PMC article. Review. - Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Musini VM, Gueyffier F, Puil L, Salzwedel DM, Wright JM. Musini VM, et al. Cochrane Database Syst Rev. 2017 Aug 16;8(8):CD008276. doi: 10.1002/14651858.CD008276.pub2. Cochrane Database Syst Rev. 2017. PMID: 28813123 Free PMC article. Review. - First-line drugs for hypertension.
Wright JM, Musini VM, Gill R. Wright JM, et al. Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD001841. doi: 10.1002/14651858.CD001841.pub3. Cochrane Database Syst Rev. 2018. PMID: 29667175 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical